Trial intelligence / Profile preview

Dose-finding study of intravenous esketamine in preschool children undergoing fracture surgery

ChiCTR2400091688Phase 4Recruiting

Sponsor
Fuyang People's Hospital
Start
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of esketamine in humerus fracture and supracondylar fracture (SCHF) (6 arms), sponsored by Fuyang People's Hospital. Primary endpoint: Separation anxiety score. Started Nov 2024; status: recruiting.

02

Drugs

esketamine
03

Conditions

humerus fracturesupracondylar fracture (SCHF)

Beyond the preview

Go deeper on ChiCTR2400091688.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400091688.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call